Stifel Starts Aeglea Biotherapeutics (AGLE) at Buy, 'has runway into 2026'
Tweet Send to a Friend
(Updated - July 25, 2023 5:20 AM EDT)
Stifel analyst Alex Thompson initiates coverage on Aeglea Biotherapeutics (NASDAQ: AGLE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Alex Thompson initiates coverage on Aeglea Biotherapeutics (NASDAQ: AGLE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
